Back

Role of fragmented QRS complex in the prognosis of patients undergoing cardiac resynchronization therapy. A new red flag to look for?

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Devices and heart failure: ICD and CRT Cardiac Resynchronisation Therapy (CRT) ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Carlos Rodriguez-Lopez

Fundacion Jimenez Diaz University Hospital, Madrid (Spain)

6 More presentations in this session

Presentation thumbnail
Efficacy of implantable cardioverter-defibrillator in non-ischemic systolic heart failure in patients with and without chronic kidney disease: an extended follow-up analysis of the DANISH trial
Doctor S. N Doi (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
A systematic review of Australian hospitals' policies on the deactivation of implantable cardioverter defibrillators
Doctor D. Grose (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Association between implanted cardioverter-defibrillator and mortality for patients with left ventricular ejection fraction near 35%
Assistant Professor J. Wasfy (Boston, US)
Abstract Slides Video
Presentation thumbnail
Effect of implantable cardioverter-defibrillator in non-ischaemic systolic heart failure according to the Heart Failure Collaboratory Medical Therapy Score: extended follow-up of the DANISH trial
Doctor A. Yafasova (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Left bundle branch area pacing in patients with CRT indication: short-term results & 1-year follow-up
Doctor V. Kataria (New Delhi, IN)
Abstract Slides

Access the full session

Session thumbnail
Devices and heart failure: ICD and CRT

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
Cardiac resynchronisation therapy
thumbnail
Congress Session
Navigating through heart failure device therapies
thumbnail
Congress Presentation
Conduction system pacing in the current treatment of HFrEF patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources